The AAPS Journal

, Volume 7, Issue 1, pp E156–E194 | Cite as

Pharmacogenomic responses of rat liver to methylprednisolone: An approach to mining a rich microarray time series

  • Richard R. Almon
  • Debra C. Dubois
  • Jin Y. Jin
  • William J. Jusko


A data set was generated to examine global changes in gene expression in rat liver over time in response to a single bolus dose of methylprednisolone. Four control animals and 43 drug-treated animals were humanely killed at 16 different time points following drug administration. Total RNA preparation from the livers of these animals were hybridized to 47 individual Affymetrix RU34A gene chips, generating data for 8799 different probe sets for each chip. Data mining techniques that are applicable to gene array time series data sets in order to identify drug-regulated changes in gene expression were applied to this data set. A series of 4 sequentially applied filters were developed that were designed to eliminate probe sets that were not expressed in the tissue, were not regulated by the drug treatment, or did not meet defined quality control standards. These filters eliminated 7287 probe sets of the 8799 total (82%) from further consideration. Application of judiciously chosen filters is an effective tool for data mining of time series data sets. The remaining data can then be further analyzed by clustering and mathematical modeling techniques.


Data mining gene arrays glucocorticoids mathematical modeling pharmacogenomics 


  1. 1.
    Bialis M, Routledge P. Adverse effects of corticosteroids.Adverse Drug React Toxicol Rev. 1998;17:227–235.Google Scholar
  2. 2.
    Frauman A. An overview of the adverse reactions to adrenal corticosteroids.Adverse Drug React Toxicol Rev. 1996;15:203–206.PubMedGoogle Scholar
  3. 3.
    Reynolds RM, Walker BR. Human insulin resistance: the role of glucocorticoids.Diabetes Obes Metab. 2003;5:5–12.PubMedCrossRefGoogle Scholar
  4. 4.
    Eisenstein A. Effects of adrenal cortical hormones on carbohydrate, protein, and fat metabolism.Am J Clin Nutr. 1973;26:113–120.PubMedGoogle Scholar
  5. 5.
    Jin JY, Almon RR, DuBois DC, Jusko WJ. Modeling of corticosteroid pharmacogenomics in rat liver using gene microarrays.J Pharmacol Exp Ther. 2003;307:93–109.PubMedCrossRefGoogle Scholar
  6. 6.
    Friedman N, Kaminski N. Statistical Methods for Analyzing Gene Expression Data for Cancer Research.Ernst Schering Research Foundation Workshop. Springer-Verlag: Berlin, Germany; 2002;38:109–131.Google Scholar
  7. 7.
    Kaminski N. Microarray analysis of idiopathic pulmonary fibrosis.Am J Respir Cell Mol Biol. 2003;29:S32-S36.PubMedGoogle Scholar
  8. 8.
    Lock C, Hermans G, Pedotti R, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.Nat Med. 2002;8:500–508.PubMedCrossRefGoogle Scholar
  9. 9.
    Sun YN, DuBois DC, Almon RR, Juskø WJ. Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.J Pharmacokinet Biopharm. 1998;26:289–317.PubMedCrossRefGoogle Scholar
  10. 10.
    Sun YN, DuBois DC, Almon RR, Pyszczynski NA, Jusko WJ. Dose-dependence and repeated-dose studies for receptor/gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.J Pharmacokinet Biopharm. 1998;26:619–648.PubMedCrossRefGoogle Scholar
  11. 11.
    Sun YN, McKay LI, DuBois DC, Jusko WJ, Almon RR. Pharmacokinetic/Pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a Receptor/Gene-mediated mechanism.J Pharmacol Exp Ther. 1999;288:720–728.PubMedGoogle Scholar
  12. 12.
    Almon RR, DuBois DC, Brandenburg EH, et al. Pharmacodynamics and pharmacogenomics of diverse receptor-mediated effects of methylprednisolone in rats using microarray analysis.J Pharmacokinet Pharmacodyn. 2002;29:103–129.PubMedCrossRefGoogle Scholar
  13. 13.
    Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns.Proc Natl Acad Sci U S A. 1998;95:1486–14868.CrossRefGoogle Scholar
  14. 14.
    Takiguchi M, Mori M. Transcriptional regulation of genes for ornithine cycle enzymes.Biochem J. 1985;312:649–659.Google Scholar
  15. 15.
    McKay LI, DuBois DC, Sun YN, Almon RR, Jusko WJ. Corticosteroid effects in skeletal muscle: gene induction/receptor autoregulation.Muscle Nerve. 1997;20:1318–1320.PubMedCrossRefGoogle Scholar
  16. 16.
    Ramakrishnan R, DuBois DC, Almon RR, Pyszczynski NA, Jusko WJ. Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats.J Pharmacokinet Pharmacodyn. 2002;29:1–24.PubMedCrossRefGoogle Scholar
  17. 17.
    Ramakrishnan R, DuBois DC, Almon RR, Pyszczynski NA, Jusko WJ. Pharmacodynamics and pharmacogenomics of methylprednisolone during 7-day infusions in rats.J Pharmacol Exp Ther. 2002;300:245–256.PubMedCrossRefGoogle Scholar
  18. 18.
    Almon RR, Chen J, Snyder G, DuBois DC, Jusko WJ Hoffman EP. In vivo multi-tissue corticosteroid microarray time series available online at Public Expression Profile Resource (PEPR).Pharmacogenomics. 2003;4:791–799.PubMedCrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2005

Authors and Affiliations

  • Richard R. Almon
    • 1
    • 2
  • Debra C. Dubois
    • 1
    • 2
  • Jin Y. Jin
    • 2
  • William J. Jusko
    • 2
  1. 1.Department of Biological SciencesState University of New York at BuffaloBuffalo
  2. 2.Department of Pharmaceutical SciencesState University of New York at BuffaloBuffalo

Personalised recommendations